The levels of oxidatively modified proteins were examined in blood from Alz
heimer's disease (AD) patients, non-AD controls, and AD relatives, Oxidativ
e modification was measured by reacting the protein carbonyls with 2,4-dini
trophenyl hydrazine (DNPH). The total oxidized proteins were determined by
HPLC, while specific protein oxidation was assessed from Western blots of e
lectrophoretic gels using antibody to the DNP derivatives. Statistically si
gnificant elevations (P < 0.05) of total oxidized proteins were observed in
both AD subjects and AD relatives when compared with non-AD controls. More
over, a protein band (e.g., MW = 78-kDa) was uniquely oxidized in the plasm
a of AD subjects. Furthermore, this protein from AD subjects was more susce
ptible to in vitro oxidation. These data suggest that such oxidized protein
s may be useful as biomarkers for the detection and evaluation of AD. (C) 2
000 Academic Press.